Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine,Adsorbed (Beijing Minhai Biotechnology)

吸附无细胞百白破联合疫苗（北京民海生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDiphtheria,Tetanus and Acellular Pertussis Combined Vaccine,Adsorbed (Beijing Minhai Biotechnology)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Combination vaccineVaccines > National Immunization Program > Immunization program vaccine(Class I)
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTetanusDiphtheriaWhooping Cough
Global Approved IndicationsTetanusDiphtheriaWhooping Cough
Approved Indications in ChinaTetanusDiphtheriaWhooping Cough
Original Approved Country/TerritoryMainland China
Original Approved Date2020/02/25
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Minhai Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Minhai Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsTetanusDiphtheriaWhooping Cough
Inactive IndicationsN/A

Other Information

ATC CodeJ07AJ52
Related LinksN/A